Abstract

Objective:

The aim of this study was to document some measurable thoracic computed tomography (CT) parameters investigated as a risk factors for prognosis in patients with coronavirus disease-2019 (COVID-19).

Materials and Methods:

We retrospectively analysed the patients with COVID-19 infection in three groups. Group 1 patients were the patients who were treated in the inpatient clinic or at home for COVID-19 pneumonia, group 2 patients consisted of patients who survived after treatment for COVID-19 pneumonia in intensive care unit (ICU), group 3 patients consisted of patients who died during treatment for COVID-19 pneumonia in the ICU. We evaluated the diameter of the aorta (A) and pulmonary artery (PA), PA/A ratio, cardiothoracic ratio (CTR), the fat to muscle ratio, and paraspinal muscle density as CT parameters evaluated as risk factors for COVID-19 infection.

Results:

The median age of all patients was 67 (Q1: 58-Q3: 75) and 60,6 % (n=143) of the patients were male. CTR was the only parameter for admission to ICU found statistically significant in multivariate analysis for both men and women. Additionally, it was the only significant risk factor for death in patients with COVID-19 infection. Although not statistically significant, the diameter of PA was found to be high in all groups. The other parameters evaluated did not provide statistically significant results between the groups.

Conclusion:

CTR may be taken into consideration as a potential risk factor in the evaluation of the patients with COVID-19 infections The diameter of PA was found to be higher in all groups so it might be an indicator of inflammation of the lungs.

Keywords: CT, COVID-19, metabolic

References

  1. Karam M, Althuwaikh S, Alazemi M, Abul A, Hayre A, Alsaif A, et al. Chest CT versus RT-PCR for the detection of COVID-19: systematic review and meta-analysis of comparative studies. JRSM Open 2021;12:20542704211011837.
  2. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323:2052-9.
  3. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55:2000547.
  4. Zouk AN, Gulati S, Xing D, Wille KM, Rowe SM, Wells JM. Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study. PLoS One 2020;15:e0229173.
  5. Wells JM, Morrison JB, Bhatt SP, Nath H, Dransfield MT. Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD. Chest 2016;149:1197-204.
  6. Ogata H, Kumasawa J, Fukuma S, Mizobuchi M, Kinugasa E, Fukagawa M,et al. The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study. Clin Exp Nephrol 2017;21:797-806.
  7. Okute Y, Shoji T, Hayashi T, Kuwamura Y, Sonoda M, Mori K, et al. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients. J Atheroscler Thromb 2017;24:412-21.
  8. Eslami V, Abrishami A, Zarei E, Khalili N, Baharvand Z, Sanei-Taheri M. The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19. Acad Radiol 2021;28:8-17.
  9. Gualtieri P, Falcone C, Romano L, Macheda S, Correale P, Arciello P, et al. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity. Int J Mol Sci 2020;21:4670.
  10. Yang Y, Ding L, Zou X, Shen Y, Hu D, Hu X, et al. Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV-2. Obesity (Silver Spring) 2020;28:2040-8.
  11. Chandarana H, Dane B, Mikheev A, Taffel MT, Feng Y, Rusinek H. Visceral adipose tissue in patients with COVID-19: risk stratification for severity. Abdom Radiol (NY) 2021;46:818-25.
  12. Miller J, Singer A, Hinrichs C, Contractor S, Doddakashi S. Cardiac Dimensions Derived From Helical Ct: Correlation With Plain Film Radiography. The international journal of radiology 1999;1:1-6.
  13. Gollub MJ, Panu N, Delaney H, Sohn M, Zheng J, Moskowitz CS, et al. Shall we report cardiomegaly at routine computed tomography of the chest? J Comput Assist Tomogr 2012;36:67-71.
  14. Truong QA, Massaro JM, Rogers IS, Mahabadi AA, Kriegel MF, Fox CS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging 2012;5:147-54.
  15. Spagnolo P, Cozzi A, Foà RA, Spinazzola A, Monfardini L, Bnà C, et al. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients. Quant Imaging Med Surg 2020;10:1325-33.
  16. Kottlors J, Zopfs D, Fervers P, Bremm J, Abdullayev N, Maintz D, et al. Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study. Eur J Radiol 2020;132:109274.
  17. Schiaffino S, Albano D, Cozzi A, Messina C, Arioli R, Bnà C, et al. CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19. Radiology 2021;300:E328-36.
  18. Ufuk F, Demirci M, Sagtas E, Akbudak IH, Ugurlu E, Sari T. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients. Eur J Radiol 2020;131:109271.
  19. Giraudo C, Librizzi G, Fichera G, Motta R, Balestro E, Calabrese F, et al. Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients. PLoS One 2021;16:e0253433.
  20. Besutti G, Pellegrini M, Ottone M, Cantini M, Milic J, Bonelli E, et al. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One 2021;16:e0251768.
  21. Kalligeros M, Shehadeh F, Mylona EK, Benitez G, Beckwith CG, Chan PA, et al. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity (Silver Spring) 2020;28:1200-4.
  22. Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 2017;13:851-63.

How to cite?

1.
Kayahan Ulu EM, Terzi Ö. CT Measured Cardiovascular and Metabolic Risk Factors in Patients with COVID-19 Infections. Turk J Intensive Care. 2022;20:39-47. https://doi.org/10.4274/tybd.galenos.2022.18199